Organic potassium salts
Sigma Aldrich Fine Chemicals Biosciences Potassium hydrogen phthalate, 877-24-7, MFCD00013070, 500 g
Linear Formula: HOOCC6H4COOK, Molecular Weight: 204.22, BioXtra, ≥99.95%, Synonym: KHP, Phthalic acid monopotassium salt, Potassium biphthalate, Potassium hydrogen phthalate, Potassium phthalate monobasic.
eMolecules 13963-58-1 | Potassium hexacyanocobaltate(III) | MFCD00011391 | 5g
Medchem Express | T-3764518 | 5mg | 686240062 | HY-102045 | 1809151-56-1 | 473.379 | C20H17F6N5O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC Acesulfame potassium | 55589-62-3 | MFCD00043833 | 99.38% | 100 G
Acesulfame potassium | 55589-62-3 | MFCD00043833 | 99.38% | 100 G
eMolecules 1111732-87-6 | Ambeed | Potassium 4-Pyridyltrifluoroborate | 1g | 525122433 | A206834 | MFCD09038543 | 185 | C5H4BF3KN
Ambeed | 3-Cyano-1H-pyrazole-5-carboxylic acid | 1g | 494129248 | A411525 | 1187361-13-2 | MFCD09036046 | 137.098 | C5H3N3O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Bleximenib oxalate | 2866179-95-3 | 98.0% | 689.82 | 1 MG
Bleximenib oxalate is an orally active and selective menin-KMT2A inhibitor with IC50 values of 0.1 nM, 0.045 nM, and ≤0.066 nM for humans, mice, and dogs, respectively. It can inhibit the proliferation and induce apoptosis and differentiation of tumor cells, making it suitable for research into tumors such as leukemia.
- Orally active and selective menin-KMT2A inhibitor
- Inhibits proliferation and induces apoptosis and differentiation of tumor cells
- Reduces expression of MEIS1, PBX3, FLT3, and JMJD1C
- Exhibits anti-tumor activity in mouse models of leukemia
Medchemexpress LLC Bleximenib (oxalate) | 2866179-95-3 | MFC32H50FN7O3.C2H2O4 | 98.0% | 689.82 | 100 MG
Bleximenib oxalate (JNJ-75276617) is an orally active and selective menin-KMT2A inhibitor. It exhibits IC50 values of 0.1 nM, 0.045 nM, and ≤0.066 nM for humans, mice, and dogs, respectively. This compound can inhibit the proliferation and induce apoptosis and differentiation of tumor cells, making it valuable for research into tumors such as leukemia.
- Orally active and selective menin-KMT2A inhibitor
- Inhibits proliferation of tumor cells
- Induces apoptosis and differentiation of tumor cells
- Exhibits anti-tumor activity in mouse models of leukemia
- Reduces expression of MEIS1, PBX3, FLT3, and JMJD1C in MOLM-14 and OCI-AML3 cells
TARGETMOL CHEMICALS INC Naloxegol oxalate 50MG
Also available in 1 mL, 5 mg, 10 mg, 25 mg and bulk. Please contact Fisher for quotes. Naloxegol oxalate (NKTR-118) is a peripherally-selective opioid antagonist for the treatment of opioid-induced constipation. Purity 99.82%
Medchemexpress LLC L-703606 oxalate hydrate | 99.4% | 508.44 | 10 MG
L-703606 oxalate hydrate is a potent and selective antagonist of the NK1 receptor. It is used for the study of gastric acid secretion.
- Potent, selective NK1 receptor antagonist
- Used for the study of gastric acid secretion
eMolecules 84-73-1 | BIS(2-HYDROXYETHYL) PHTHALATE | MFCD27920521 | 1g
AstaTech | BIS(2-HYDROXYETHYL) PHTHALATE | 1g | 589954328 | C76700 | 95.000 | 84-73-1 | MFCD27920521 | 254.238 | C12H14O6
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Selleck Chemical LLC Phospho(enol)pyruvic acid monopotassium salt S3335-25mg
Phospho(enol)pyruvic acid monopotassium salt (Potassium 1-carboxyvinyl hydrogenphosphate) is an endogenous metabolite
Medchemexpress LLC Naloxegol oxalate | 1354744-91-4 | 99.9% | C36H55NO15 | 5 MG
Naloxegol oxalate is an orally active, peripherally acting μ-opioid receptor antagonist (target Ki 7.42 nmol/L). It inhibits opioid binding to gastrointestinal μ-opioid receptors, alleviating opioid-induced gastrointestinal hypomotility, delayed transit, hypertonicity, and increased fluid reabsorption. It is applicable for research into opioid-induced constipation.
- Orally active
- Peripherally acting μ-opioid receptor antagonist
- Inhibits opioid binding to gastrointestinal μ-opioid receptors
- Alleviates opioid-induced gastrointestinal hypomotility and related issues
- Applicable to research on opioid-induced constipation
- High affinity binding to μ and κ-opioid receptors in vitro
- Low affinity to δ-opioid receptors in vitro
- No significant activity at non-opioid targets in vitro
- Available in solid and solution forms
TARGETMOL CHEMICALS INC Naftidrofuryl oxalate 500MG
Also available in 1 mL, 50 mg, 100 mg, 200 mg and bulk. Please contact Fisher for quotes. Naftidrofuryl oxalate (Nafronyl oxalate) is a drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. It may also be an antagonist at 5HT-2 serotonin receptors. Purity 98.38%